SCHEMBL7670580

SCHEMBL7670580

O=C1[N]CCCN1c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
SIGMAR1 Q99720 3/20 0.48
DDB1 Q16531 1/20 0.42
CRBN Q96SW2 1/20 0.42
GAA P10253 3/20 0.41
DRD3 P35462 2/20 0.38
DRD2 P14416 1/20 0.38
KDM4E B2RXH2 2/20 0.38
MAPT P10636 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
HDAC4 P56524 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
ALOX5 P09917 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.37
CHRM2 P08172 1/20 0.37
CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2490664 0.88 SIGMAR1 (0.57) NPC1RAB9AMEN1KMT2ASIGMAR1
SCHEMBL6362002 0.73 NPC1 (0.82) NPC1RAB9AMEN1KMT2ASIGMAR1
SCHEMBL3696484 0.71 CHKA (0.42) NPC1RAB9AMEN1KMT2ASIGMAR1
SCHEMBL136476 0.69 ALDH1A1 (0.67) NPC1RAB9AMEN1KMT2ADDB1
SCHEMBL13116710 0.69 SIGMAR1 (0.48) NPC1RAB9AMEN1KMT2ASIGMAR1
SCHEMBL8579495 0.69 CA1 (0.44) RAB9AMEN1KMT2ASIGMAR1DRD3
SCHEMBL7549211 0.69 SIGMAR1 (0.53) NPC1RAB9AMEN1KMT2ASIGMAR1
SCHEMBL76559 0.68 ALDH1A1 (0.59) NPC1RAB9AMEN1KMT2ADDB1
SCHEMBL27409503 0.68 ALDH1A1 (0.59) NPC1RAB9AMEN1KMT2ADDB1
Hydrochloric Acid SCHEMBL7466356 0.68 ALDH1A1 (0.65) NPC1RAB9AMEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6365602-B1 FOR THERAPY OF DEPRESSION, ANXIETY, ASTHMA, PAIN, INFLAMMATION, URINARY INCONTINENCE AND OTHER DISEASE CONDITIONS ASTRA ZENECA AB (SE) 2002-04-02 US disclosed